Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Sativex
Active Ingredients: Cannabidiol 25mg/mL equivalent to cannabis sativa extract 35mg-42mg
Tetrahydrocannabinol 27mg/mL equivalent to cannabis sativa extract 38mg-44mg
Dosage Form: Oral spray
New Zealand Sponsor: Health Support Limited
Manufacturer: GW Pharma Limited, Kent, United Kingdom
Dated this 17th day of March 2011.
PAT TUOHY, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).